Financial & competing interests disclosure
W Abraham has received consulting fees from Cardiokinetix, Inc., for his work as Principal Investigator of the US PARACHUTE Feasibility Study and Co-Principal Investigator for the ongoing PARACHUTE IV randomized controlled trial. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.